Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MicroPort NeuroScientificHKSE:02172 -1.20%93 FCF Margin % is 42.48% as of Dec. 2025, which is 118% above its 10-year median of 19.53. GuruFocus rates HKSE:02172 with a GF Score™ of 93/100 and a GF Value™ of HK$13.19 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 814 Medical Devices & Instruments companies, MicroPort NeuroScientific ranks better than 90.79% on this metric.
The historical rank and industry rank for MicroPort NeuroScientific's FCF Margin % or its related term are showing as below:
HKSE:02172'
s FCF Margin % Range Over the Past 10 Years
Min: -7.34 Med: 19.53 Max: 32.13
Current: 19.65
During the past 7 years, the highest FCF Margin % of MicroPort NeuroScientific was 32.13%. The lowest was -7.34%. And the median was 19.53%.
HKSE:02172's FCF Margin % is ranked better than 90.79% of 814
companies
in the Medical Devices & Instruments industry
Industry Median: -0.815
vs HKSE:02172: 19.65
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02172 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, MicroPort NeuroScientific's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort NeuroScientific FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroScientific's FCF Margin % distribution charts can be found below:
* The bar in red indicates where MicroPort NeuroScientific's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroPort NeuroScientific (HKSE:02172) has a FCF Margin % of 42.48% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on MicroPort NeuroScientific and its competitors. This is 118% above median its historical median of 19.53. According to the industry distribution chart, MicroPort NeuroScientific ranks #75 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 9.2%.
Is MicroPort NeuroScientific's FCF Margin % too high?
MicroPort NeuroScientific's current FCF Margin % of 42.48% is 118% above median its 10-year median of 19.53. Based on the distribution chart, MicroPort NeuroScientific ranks #75 out of 814 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, MicroPort NeuroScientific has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort NeuroScientific's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort NeuroScientific ranks #75 out of 814 companies for FCF Margin %. This places MicroPort NeuroScientific in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on MicroPort NeuroScientific and its competitors. MicroPort NeuroScientific's current FCF Margin % is 42.48%, which is 118% above median its own 10-year median of 19.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort NeuroScientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort NeuroScientific (HKSE:02172) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.19, compared to a current price of HK$9.02 — trading 31.6% below its estimated fair value. The current FCF Margin % is 42.48%, which is 118% above median its 10-year median of 19.53. MicroPort NeuroScientific's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For MicroPort NeuroScientific (HKSE:02172), the current FCF Margin % is 42.48% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort NeuroScientific (HKSE:02172) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort NeuroScientific stock appears to be undervalued.
The current stock price of HK$9.02 is trading 31.6% below its estimated GF Value™ of HK$13.19.
GuruFocus considers MicroPort NeuroScientific to be Possible Value Trap.
Key valuation signals for HKSE:02172:
FCF Margin %: 42.48% (118% above median its 10-year median of 19.53)
GF Value™: HK$13.19 vs. price of HK$9.02 (31.6% below fair value)
No single metric tells the full story. See the HKSE:02172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
93GF Score
Get the complete analysis for HKSE:02172
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02172 has been successfully added to your 
